Home > Insider Trading > Filing (0001209191-22-060689)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1841387	Candel Therapeutics Inc.	CADL	Biological Products, (No Disgnostic Substances) (2836)	522214851

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1873905	Peter Paul Tak	C/O Candel Therapeutics, Inc. 117 Kendrick St., Suite 450 Needham MA 02494	Chief Executive Officer	Yes	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2022-12-08	3,050	$1.70	28,050	No	4	P	Direct
Common Stock	Acquisiton	2022-12-09	12,935	$1.92	40,985	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct
No	4	P	Direct

Footnotes

The price in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $1.55 to $1.80. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effected.
The price in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $1.89 to $2.00. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effected.